_version_ 1784845789512597504
author Takashita, Emi
Yamayoshi, Seiya
Halfmann, Peter
Wilson, Nancy
Ries, Hunter
Richardson, Alex
Bobholz, Max
Vuyk, William
Maddox, Robert
Baker, David A.
Friedrich, Thomas C.
O’Connor, David H.
Uraki, Ryuta
Ito, Mutsumi
Sakai-Tagawa, Yuko
Adachi, Eisuke
Saito, Makoto
Koga, Michiko
Tsutsumi, Takeya
Iwatsuki-Horimoto, Kiyoko
Kiso, Maki
Yotsuyanagi, Hiroshi
Watanabe, Shinji
Hasegawa, Hideki
Imai, Masaki
Kawaoka, Yoshihiro
author_facet Takashita, Emi
Yamayoshi, Seiya
Halfmann, Peter
Wilson, Nancy
Ries, Hunter
Richardson, Alex
Bobholz, Max
Vuyk, William
Maddox, Robert
Baker, David A.
Friedrich, Thomas C.
O’Connor, David H.
Uraki, Ryuta
Ito, Mutsumi
Sakai-Tagawa, Yuko
Adachi, Eisuke
Saito, Makoto
Koga, Michiko
Tsutsumi, Takeya
Iwatsuki-Horimoto, Kiyoko
Kiso, Maki
Yotsuyanagi, Hiroshi
Watanabe, Shinji
Hasegawa, Hideki
Imai, Masaki
Kawaoka, Yoshihiro
author_sort Takashita, Emi
collection PubMed
description
format Online
Article
Text
id pubmed-9730936
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Massachusetts Medical Society
record_format MEDLINE/PubMed
spelling pubmed-97309362022-12-09 In Vitro Efficacy of Antiviral Agents against Omicron Subvariant BA.4.6 Takashita, Emi Yamayoshi, Seiya Halfmann, Peter Wilson, Nancy Ries, Hunter Richardson, Alex Bobholz, Max Vuyk, William Maddox, Robert Baker, David A. Friedrich, Thomas C. O’Connor, David H. Uraki, Ryuta Ito, Mutsumi Sakai-Tagawa, Yuko Adachi, Eisuke Saito, Makoto Koga, Michiko Tsutsumi, Takeya Iwatsuki-Horimoto, Kiyoko Kiso, Maki Yotsuyanagi, Hiroshi Watanabe, Shinji Hasegawa, Hideki Imai, Masaki Kawaoka, Yoshihiro N Engl J Med Correspondence Massachusetts Medical Society 2022-11-16 /pmc/articles/PMC9730936/ /pubmed/36383452 http://dx.doi.org/10.1056/NEJMc2211845 Text en Copyright © 2022 Massachusetts Medical Society. All rights reserved. http://www.nejmgroup.org/legal/terms-of-use.htm This article is made available via the PMC Open Access Subset for unrestricted re-use, except commercial resale, and analyses in any form or by any means with acknowledgment of the original source. PMC is granted a license to make this article available via PMC and Europe PMC, subject to existing copyright protections.
spellingShingle Correspondence
Takashita, Emi
Yamayoshi, Seiya
Halfmann, Peter
Wilson, Nancy
Ries, Hunter
Richardson, Alex
Bobholz, Max
Vuyk, William
Maddox, Robert
Baker, David A.
Friedrich, Thomas C.
O’Connor, David H.
Uraki, Ryuta
Ito, Mutsumi
Sakai-Tagawa, Yuko
Adachi, Eisuke
Saito, Makoto
Koga, Michiko
Tsutsumi, Takeya
Iwatsuki-Horimoto, Kiyoko
Kiso, Maki
Yotsuyanagi, Hiroshi
Watanabe, Shinji
Hasegawa, Hideki
Imai, Masaki
Kawaoka, Yoshihiro
In Vitro Efficacy of Antiviral Agents against Omicron Subvariant BA.4.6
title In Vitro Efficacy of Antiviral Agents against Omicron Subvariant BA.4.6
title_full In Vitro Efficacy of Antiviral Agents against Omicron Subvariant BA.4.6
title_fullStr In Vitro Efficacy of Antiviral Agents against Omicron Subvariant BA.4.6
title_full_unstemmed In Vitro Efficacy of Antiviral Agents against Omicron Subvariant BA.4.6
title_short In Vitro Efficacy of Antiviral Agents against Omicron Subvariant BA.4.6
title_sort in vitro efficacy of antiviral agents against omicron subvariant ba.4.6
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9730936/
https://www.ncbi.nlm.nih.gov/pubmed/36383452
http://dx.doi.org/10.1056/NEJMc2211845
work_keys_str_mv AT takashitaemi invitroefficacyofantiviralagentsagainstomicronsubvariantba46
AT yamayoshiseiya invitroefficacyofantiviralagentsagainstomicronsubvariantba46
AT halfmannpeter invitroefficacyofantiviralagentsagainstomicronsubvariantba46
AT wilsonnancy invitroefficacyofantiviralagentsagainstomicronsubvariantba46
AT rieshunter invitroefficacyofantiviralagentsagainstomicronsubvariantba46
AT richardsonalex invitroefficacyofantiviralagentsagainstomicronsubvariantba46
AT bobholzmax invitroefficacyofantiviralagentsagainstomicronsubvariantba46
AT vuykwilliam invitroefficacyofantiviralagentsagainstomicronsubvariantba46
AT maddoxrobert invitroefficacyofantiviralagentsagainstomicronsubvariantba46
AT bakerdavida invitroefficacyofantiviralagentsagainstomicronsubvariantba46
AT friedrichthomasc invitroefficacyofantiviralagentsagainstomicronsubvariantba46
AT oconnordavidh invitroefficacyofantiviralagentsagainstomicronsubvariantba46
AT urakiryuta invitroefficacyofantiviralagentsagainstomicronsubvariantba46
AT itomutsumi invitroefficacyofantiviralagentsagainstomicronsubvariantba46
AT sakaitagawayuko invitroefficacyofantiviralagentsagainstomicronsubvariantba46
AT adachieisuke invitroefficacyofantiviralagentsagainstomicronsubvariantba46
AT saitomakoto invitroefficacyofantiviralagentsagainstomicronsubvariantba46
AT kogamichiko invitroefficacyofantiviralagentsagainstomicronsubvariantba46
AT tsutsumitakeya invitroefficacyofantiviralagentsagainstomicronsubvariantba46
AT iwatsukihorimotokiyoko invitroefficacyofantiviralagentsagainstomicronsubvariantba46
AT kisomaki invitroefficacyofantiviralagentsagainstomicronsubvariantba46
AT yotsuyanagihiroshi invitroefficacyofantiviralagentsagainstomicronsubvariantba46
AT watanabeshinji invitroefficacyofantiviralagentsagainstomicronsubvariantba46
AT hasegawahideki invitroefficacyofantiviralagentsagainstomicronsubvariantba46
AT imaimasaki invitroefficacyofantiviralagentsagainstomicronsubvariantba46
AT kawaokayoshihiro invitroefficacyofantiviralagentsagainstomicronsubvariantba46